Kidney and Kidney-Pancreas Transplantation: Evaluation and Management

Activity Details
  • Credit Amounts:
    • CME: 0.75
    • CPE: 0.75
    • Other: 0.75
  • Cost: Free
  • Release: Dec 20, 2016
  • Expires: Dec 19, 2019
  • Estimated Time to Complete:
    45 Minutes
  • System Requirements:
  • Average User Rating:
    ( Ratings)

Faculty

Ana L.  Castellanos Ana L. Castellanos, MD
Associate Professor
University of Kentucky College of Medicine
Transplant Nephrologist
UKHealthCare
Lexington, Kentucky

Needs Statement

According to the NIH, an estimated 23 million American adults have chronic kidney disease (CKD) and the National Kidney Foundation reports that Medicare spends $31 billion annually to treat patients with kidney failure. As these numbers increase, there is growing importance for medical professionals to understand why kidney transplantation is the preferred treatment for end-stage renal disease, identify the indications and risk factors to consider before starting kidney and kidney/pancreas transplant evaluation, and be familiar with the complications of kidney and kidney/pancreas transplantation.

Target Audience

Physicians, Physician Assistants, Pharmacists, Health Administrators, Medical Assistants/Technicians, Cardiovascular Technicians, Nurses, Nurse Practitioners, Clinical Researchers

Objectives

Upon completion of this activity, participates will be able to:

  1. Explain why kidney transplantation is the preferred treatment for End Stage Renal Disease
  2. Discuss induction and maintenance immunosuppression in kidney transplant recipients
  3. Identify complications in kidney transplant patients: infectious, malignant and metabolic

Accreditation

CME
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

ACGME Competencies

  • Patient care
  • Medical knowledge
  • Practice-based learning and improvement
  • Systems-based practice

CPE
ACPEThe University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This -based activity has been assigned UAN 0022-0000-16-128-H01-P and will award 0.75 contact hours (0.075 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Other
UK Healthcare CECentral certifies this activity for 0.75 hours of participation.

Faculty Disclosure

No speakers, authors, planners have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgement

In collaboration with UK Transplant Center.